{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T21:06:29Z","timestamp":1780607189244,"version":"3.54.1"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Nonalcoholic fatty liver disease (NAFLD) is associated with several adverse clinical outcomes. In this study, we assessed the association between NAFLD and several clinical outcome measures in patients with diabetes mellitus (DM) and atrial fibrillation (AF).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We queried the National Inpatient Sample (NIS) between 2016 and 2019 for adult patients who were hospitalized with DM and AF. NAFLD was the independent variable. The primary outcome was inpatient mortality. The secondary outcomes were cardiogenic shock, cardiac arrest, gastrointestinal bleeding (GIB), invasive mechanical ventilation, length of stay, and total hospital charges. A multivariable logistic regression model was used to estimate odds ratios with a 95% confidence interval (CI) and a <jats:italic toggle=\"yes\">P<\/jats:italic> value of less than 0.05 was considered significant.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>There were 6\u2005723\u2005293 hospitalizations with AF and DM and 253\u2005639 (3.7%) had NAFLD. NAFLD and non-NAFLD cohorts had a mean age of 70.4 vs. 73.8 years, respectively. Overall, 55.6% were male and 73.8% were White. NAFLD was found to be significantly associated with in-hospital mortality [adjusted odds ratio (AOR), 4.2; 95% CI, 4.08\u20134.32], cardiogenic shock (AOR, 4.78; 95% CI, 4.59\u20134.98), cardiac arrest (AOR, 3.43; 95% CI, 3.27\u20133.59), GIB (AOR, 1.92; 95% CI, 1.86\u20131.98), length of stay, and total hospital charges.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>In patients with AF and DM patients, the presence of NAFLD was associated with significantly worse clinical outcomes and higher resource utilization. Adverse cardiovascular events were common as well as GIB. Screening and prevention strategies modifying the risk and disease severity of NAFLD are needed.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/xce.0000000000000307","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T13:18:29Z","timestamp":1717593509000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Patients with atrial fibrillation and diabetes mellitus affected by nonalcoholic fatty liver disease have a greater risk of mortality and worse clinical outcomes"],"prefix":"10.1097","volume":"13","author":[{"given":"Leonid","family":"Khokhlov","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Good Samaritan Hospital, TriHealth, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bekure","family":"Siraw","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ascension Saint Joseph Hospital, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehnaaz","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Good Samaritan Hospital, TriHealth, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Hussain","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Good Samaritan Hospital, TriHealth, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Shemisa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Good Samaritan Hospital, TriHealth, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,6,4]]},"reference":[{"key":"R1-20240916","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/hep.29721","article-title":"Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis.","volume":"68","author":"Younossi","year":"2018","journal-title":"Hepatology"},{"key":"R2-20240916","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","article-title":"Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters.","volume":"49","author":"Cobbina","year":"2017","journal-title":"Drug Metab Rev"},{"key":"R3-20240916","doi-asserted-by":"crossref","first-page":"198.e2","DOI":"10.1016\/j.cgh.2017.09.041","article-title":"Racial and ethnic disparities in nonalcoholic fatty liver disease prevalence, severity, and outcomes in the United States: a systematic review and meta-analysis.","volume":"16","author":"Rich","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R4-20240916","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jhep.2021.02.034","article-title":"Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort.","volume":"75","author":"Harrison","year":"2021","journal-title":"J Hepatol"},{"key":"R5-20240916","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1016\/j.cgh.2021.12.015","article-title":"Prevalence of high and moderate risk nonalcoholic fatty liver disease among adults in the United States, 1999-2016.","volume":"20","author":"Golabi","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R6-20240916","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology"},{"key":"R7-20240916","first-page":"2","article-title":"Non-alcoholic fatty liver disease (NAFLD), active component, US Armed Forces, 2000-2017.","volume":"26","author":"Williams","year":"2019","journal-title":"MSMR"},{"key":"R8-20240916","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe.","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"R9-20240916","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/eurjpc\/zwab212","article-title":"Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis.","volume":"29","author":"Alon","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"R10-20240916","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis.","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"R11-20240916","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2337\/dc19-1113","article-title":"Economic and clinical burden of nonalcoholic steatohepatitis in patients with type 2 diabetes in the US.","volume":"43","author":"Younossi","year":"2020","journal-title":"Diabetes Care"},{"key":"R12-20240916","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/5584_2020_532","article-title":"Non-alcoholic fatty liver disease and diabetes mellitus.","volume":"1307","author":"Khneizer","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"R13-20240916","doi-asserted-by":"crossref","first-page":"e0241770","DOI":"10.1371\/journal.pone.0241770","article-title":"Nineteen-year prognosis in Japanese patients with biopsy-proven nonalcoholic fatty liver disease: lean versus overweight patients.","volume":"15","author":"Hirose","year":"2020","journal-title":"PLoS One"},{"key":"R14-20240916","doi-asserted-by":"crossref","first-page":"773342","DOI":"10.3389\/fendo.2021.773342","article-title":"Association between diabetes mellitus and all-cause and cardiovascular mortality among individuals with ultrasound-defined non-alcoholic fatty liver disease.","volume":"12","author":"Wu","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R15-20240916","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.clinre.2017.08.001","article-title":"The association between non-alcoholic fatty liver disease and atrial fibrillation: a meta-analysis.","volume":"41","author":"Wijarnpreecha","year":"2017","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R16-20240916","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s11739-021-02682-3","article-title":"Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. a prospective multicenter cohort study.","volume":"16","author":"Pastori","year":"2021","journal-title":"Intern Emerg Med"},{"key":"R17-20240916","article-title":"Medical Expenditure Panel Survey. Home."},{"key":"R18-20240916","article-title":"Statistical software for data science."},{"key":"R19-20240916","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2337\/dc17-1590","article-title":"Cardiovascular disease, cancer, and mortality among people with type 2 diabetes and alcoholic or nonalcoholic fatty liver disease hospital admission.","volume":"41","author":"Wild","year":"2017","journal-title":"Diabetes Care"},{"key":"R20-20240916","doi-asserted-by":"crossref","first-page":"e745","DOI":"10.1210\/clinem\/dgab644","article-title":"Metabolic dysfunction-associated fatty liver disease and mortality among Chinese adults: a prospective cohort study.","volume":"107","author":"Wang","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"R21-20240916","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1007\/s10620-013-2743-5","article-title":"Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD).","volume":"58","author":"Stepanova","year":"2013","journal-title":"Dig Dis Sci"},{"key":"R22-20240916","doi-asserted-by":"crossref","DOI":"10.1177\/03000605211047074","article-title":"Relationship between non-alcoholic fatty liver disease and cardiac arrhythmia: a systematic review and meta-analysis.","volume":"49","author":"Gong","year":"2021","journal-title":"J Int Med Res"},{"key":"R23-20240916","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1159\/000514953","article-title":"NASH\/liver fibrosis prevalence and incidence of nonliver comorbidities among people with NAFLD and incidence of NAFLD by metabolic comorbidities: lessons from South Korea.","volume":"39","author":"Park","year":"2021","journal-title":"Dig Dis"},{"key":"R24-20240916","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1136\/gutjnl-2021-325724","article-title":"Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort.","volume":"71","author":"Simon","year":"2022","journal-title":"Gut"},{"key":"R25-20240916","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.numecd.2014.01.005","article-title":"Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes.","volume":"24","author":"Targher","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R26-20240916","doi-asserted-by":"crossref","first-page":"101199","DOI":"10.1016\/j.cpcardiol.2022.101199","article-title":"Association of non-alcoholic fatty liver disease with in-hospital outcomes in primary heart failure hospitalizations with reduced or preserved ejection fraction.","volume":"48","author":"Minhas","year":"2022","journal-title":"Curr Probl Cardiol"},{"key":"R27-20240916","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease.","volume":"385","author":"Sanyal","year":"2021","journal-title":"N Engl J Med"},{"key":"R28-20240916","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4254\/wjh.v15.i1.79","article-title":"Influence of non-alcoholic fatty liver disease on non-variceal upper gastrointestinal bleeding: a nationwide analysis.","volume":"15","author":"Soni","year":"2023","journal-title":"World J Hepatol"},{"key":"R29-20240916","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/MEG.0000000000001920","article-title":"Obstructive sleep apnea and severity of nonalcoholic fatty liver disease.","volume":"33","author":"Krolow","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R30-20240916","first-page":"36","article-title":"The impact of nonalcoholic fatty liver disease on severe community-acquired pneumonia outcomes.","volume":"13","author":"Gjura\u0161in","year":"2022","journal-title":"Life (Basel)"},{"key":"R31-20240916","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/hep.30094","article-title":"Healthcare cost and utilization in nonalcoholic fatty liver disease: real-world data from a large US claims database.","volume":"68","author":"Allen","year":"2018","journal-title":"Hepatology"}],"container-title":["Cardiovascular Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/XCE.0000000000000307","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T18:43:09Z","timestamp":1726512189000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/XCE.0000000000000307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,4]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/xce.0000000000000307","relation":{},"ISSN":["2574-0954"],"issn-type":[{"value":"2574-0954","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,4]]}}}